$2.56T
Total marketcap
$45.78B
Total volume
BTC 51.17%     ETH 16.82%
Dominance

Adynxx ADYX Stock

0 USD {{ price }} -99.000000% {{change_pct}}%
Market Cap
871 USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
601 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.03 USD

Adynxx Price Chart

Adynxx ADYX Financial and Trading Overview

Adynxx stock price 0.0000 USD
Previous Close 0.0001 USD
Open 0.0001 USD
Bid 0 USD x 800
Ask 0 USD x 1300
Day's Range 0.0001 - 0.0001 USD
52 Week Range 0.0001 - 0.0003 USD
Volume 7 USD
Avg. Volume 162 USD
Market Cap 87.12K USD
Beta (5Y Monthly) 2.616013
PE Ratio (TTM) N/A
EPS (TTM) -0.03 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date May 6, 2019
1y Target Est 2.8 USD

ADYX Valuation Measures

Enterprise Value 9.76M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.241

Trading Information

Adynxx Stock Price History

Beta (5Y Monthly) 2.616013
52-Week Change 0%
S&P500 52-Week Change 20.43%
52 Week High 0.0003 USD
52 Week Low 0.0001 USD
50-Day Moving Average 0.000124 USD
200-Day Moving Average 0.000181 USD

ADYX Share Statistics

Avg. Volume (3 month) 162 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 5.81M
Float 1.03M
Short Ratio 2.86
% Held by Insiders 0%
% Held by Institutions 0.011%
Shares Short 25.83K
Short % of Float 0.45%
Short % of Shares Outstanding 0.44%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:6

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2018
Most Recent Quarter (mrq) September 30, 2019
Next Fiscal Year End December 31, 2019

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -192.34%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -7869000 USD
Net Income Avi to Common (ttm) -10509000 USD
Diluted EPS (ttm) -0.03
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 331K USD
Total Cash Per Share (mrq) 0.06 USD
Total Debt (mrq) 10.09M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.184
Book Value Per Share (mrq) -1.905

Cash Flow Statement

Operating Cash Flow (ttm) -6137000 USD
Levered Free Cash Flow (ttm) -6112963 USD

Profile of Adynxx

Country United States
State CA
City San Francisco
Address 100 Pine Street
ZIP 94111
Phone 415-512-7740
Website https://www.adynxx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 6

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.

Q&A For Adynxx Stock

What is a current ADYX stock price?

Adynxx ADYX stock price today per share is 0.0000 USD.

How to purchase Adynxx stock?

You can buy ADYX shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Adynxx?

The stock symbol or ticker of Adynxx is ADYX.

Which industry does the Adynxx company belong to?

The Adynxx industry is Biotechnology.

How many shares does Adynxx have in circulation?

The max supply of Adynxx shares is 0.

What is Adynxx Price to Earnings Ratio (PE Ratio)?

Adynxx PE Ratio is now.

What was Adynxx earnings per share over the trailing 12 months (TTM)?

Adynxx EPS is -0.03 USD over the trailing 12 months.

Which sector does the Adynxx company belong to?

The Adynxx sector is Healthcare.